Physician profile
Sally Boyd
NPI 1295223246
$2,870.40
in general payments reported to CMS, 2019-2025
7 companies · $326 in 2025
The $326 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $105 · 2021: $434 · 2022: $958 · 2023: $456 · 2024: $591 · 2025: $326.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,157 · Education: $216.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,157.43 |
| Education | $216.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,994.56 | 2021-2025 | Endurant Iis, In.Pact Admiral |
| Silk Road Medical, INC. | $254.20 | 2022-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Polynovo North America LLC | $146.64 | 2024 | Novosorb Btm |
| Shockwave Medical, INC | $143.72 | 2025 | |
| Bolton Medical INC | $142.11 | 2023 | Relay Thoracic Stent-Graft With Plus Delivery System |
| Medtronic Vascular, INC. | $105.06 | 2020 | |
| Alexion Pharmaceuticals, INC. | $84.11 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sally Boyd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.